Case Report
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Apr 16, 2013; 5(4): 180-185
Published online Apr 16, 2013. doi: 10.4253/wjge.v5.i4.180
Table 2 Naranjo adverse drug reaction nomogram in our patient
YesNoOur patient
1: Are there previous conclusive reports on this reaction?100
2: Did the adverse event appear after the suspected drug was administered?2-12
3: Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?101
4: Did the adverse reaction reappear when the drug was readministered?2-10
5: Are there alternative causes (other than the drug) that could have, on their own, caused the reaction?-122
6: Did the reaction appear when a placebo was given?-111
7: Was the drug detected in the blood (or other fluids) in concentration known to be toxic?100
8: Was the reaction more severe when the dose was increased or less severe when dose was decreased?100
9: Did the patient have a similar reaction to the same or similar drugs in any previous exposure?100
10: Was the adverse event confirmed by any objective evidence?101